Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] - N0000193926

Pharmacologic Class Information

Pharmacologic Code N0000193926
Pharmacologic Name Insulin-like Growth Factor-1 Receptor Inhibitor
Pharmacologic Uses
  • insulin-like growth factor-1 receptor inhibitor
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Insulin-like Growth Factor-1 Receptor Inhibitor

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Insulin-like Growth Factor-1 Receptor Inhibitor [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
75987-130Tepezza Non-Proprietary Name: TeprotumumabInjection, Powder, Lyophilized, For SolutionIntravenousHorizon Therapeutics Usa, Inc.ACTIVE